HWH:NASDAQHWH International Inc. Analysis
Data as of 2026-04-09 - not real-time
$1.03
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: HWH trades at $1.03, well below its 20‑day, 50‑day and 200‑day SMAs of $1.26, $1.39 and $1.84, confirming a bearish trend. The 14‑day RSI sits at 39, hinting at slight oversold conditions, but the MACD line is under the signal line, generating a bearish histogram. Volume is increasing, yet the 30‑day volatility is an extreme 182%, and the stock has suffered an 85% max drawdown, underscoring price instability. Market sentiment is unusually bullish – the Fear & Greed Index reads “Extreme Greed” at 83.27 – which appears disconnected from the price action.
Fundamental outlook: The company reports negative operating margins (-36.9%) and zero net profit, with EBITDA of -$3.05 M and free cash flow of -$0.88 M, indicating severe cash‑flow strain. Despite holding $2.17 M in cash, debt of $0.85 M yields a high debt‑to‑equity of 31.5, and ROE/ROA are deeply negative. Valuation multiples (P/B 2.94, P/S 8.88) are high for a firm with no earnings, and there is no dividend. The combination of weak fundamentals, high volatility, and thin market cap (~$7.7 M) suggests the stock is overvalued relative to its financial health.
Fundamental outlook: The company reports negative operating margins (-36.9%) and zero net profit, with EBITDA of -$3.05 M and free cash flow of -$0.88 M, indicating severe cash‑flow strain. Despite holding $2.17 M in cash, debt of $0.85 M yields a high debt‑to‑equity of 31.5, and ROE/ROA are deeply negative. Valuation multiples (P/B 2.94, P/S 8.88) are high for a firm with no earnings, and there is no dividend. The combination of weak fundamentals, high volatility, and thin market cap (~$7.7 M) suggests the stock is overvalued relative to its financial health.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below all major moving averages
- Bearish MACD and high short‑term volatility
- Negative operating cash flow
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- Sustained operating losses and negative margins
- Elevated debt‑to‑equity ratio
- Limited analyst coverage and unclear turnaround path
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- Fundamental deterioration with no earnings outlook
- Extreme price volatility and thin liquidity
- Lack of dividend and value creation prospects
Key Metrics & Analysis
Financial Health
Revenue Growth-81.00%
ROE-95.58%
ROA-34.98%
Debt/Equity31.53
P/B Ratio2.9
Op. Cash Flow$-1750290
Free Cash Flow$-884406
Technical Analysis
TrendBearish
RSI39.1
Support$0.88
Resistance$1.83
MA 20$1.26
MA 50$1.39
MA 200$1.84
MACDBearish
VolumeIncreasing
Fear & Greed Index83.27
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta0.28
Volatility182.21%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.